KOSPI-listed pharmaceutical firms’ operating profit plunge by 8.9% in third quarter

Published: 2011-11-17 07:00:00

Updated: 2011-11-17 07:00:00

Korea’s listed pharmaceutical companies saw their third-quarter combined operating profit fall 6.8 percent year-on-year, while net profit dwindle to 14.3%. Sales were up 6.1 percent on average.

The combined net profit of 32 firms listed on the main bourse came to 24.2 billion for the third qua...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK